Main menu button

Nyheter

European Debt Markets Q3 2025 – Carlsquare Insights
12 nov 2025
European Debt Markets Q3 2025 – Carlsquare Insights
Insights
Equity Research Biosergen: Candidozyma auris on the rise in Europe
17 sep 2025
Equity Research Biosergen: Candidozyma auris on the rise in Europe
Analysmaterial Biosergen
Sector Report – The Modern Data Software Landscape
11 sep 2025
Sector Report – The Modern Data Software Landscape
Insights
Research update Biosergen: Ongoing development going according to plan
02 sep 2025
Research update Biosergen: Ongoing development going according to plan
Analysmaterial Biosergen
Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2
27 aug 2025
Equity research Nosa Plugs Q2, 2025: Growth ahead but mixed results in Q2
Analysmaterial Nosa Plugs
Equity Research Nosa Plugs: Positive results and proof of concept
11 jul 2025
Equity Research Nosa Plugs: Positive results and proof of concept
Analysmaterial Nosa Plugs
How to navigate the stock market when Sweden stumbles
30 jun 2025
How to navigate the stock market when Sweden stumbles
I pressen
The Office of the CFO is evolving – fast, tech-driven, and strategic.
17 jun 2025
The Office of the CFO is evolving – fast, tech-driven, and strategic.
Insights
Equity Research Nosa Plugs: First possible acquisition announced
16 jun 2025
Equity Research Nosa Plugs: First possible acquisition announced
Analysmaterial Nosa Plugs
Equity Research Biosergen: Stable quarter with exciting news around the corner
23 maj 2025
Equity Research Biosergen: Stable quarter with exciting news around the corner
Analysmaterial Biosergen
Analys Elicera Therapeutics, kv1 2025: Tidiga CARMA-resultat stärker förhoppningar
23 maj 2025
Analys Elicera Therapeutics, kv1 2025: Tidiga CARMA-resultat stärker förhoppningar
Analysmaterial Elicera Therapeutics
Analys Elicera Therapeutics: Lovande första resultat från första dosgrupp i CARMA-studien
22 maj 2025
Analys Elicera Therapeutics: Lovande första resultat från första dosgrupp i CARMA-studien
Analysmaterial Elicera Therapeutics
Equity research Nosa Plugs Q1, 2025: NOSA starting 2025 with consistent growth
21 maj 2025
Equity research Nosa Plugs Q1, 2025: NOSA starting 2025 with consistent growth
Analysmaterial Nosa Plugs
Current developments in the software sector landscape
21 maj 2025
Current developments in the software sector landscape
Insights
Carlsquare Global Tech Tour 2025
18 maj 2025
Carlsquare Global Tech Tour 2025
Events
Equity research Immunovia: All eyes on securing the launch of PancreaSure
15 maj 2025
Equity research Immunovia: All eyes on securing the launch of PancreaSure
Analysmaterial Immunovia
Analys Elicera Therapeutics: Bra start på 2025 med viktiga resultat runt hörnet
15 maj 2025
Analys Elicera Therapeutics: Bra start på 2025 med viktiga resultat runt hörnet
Analysmaterial Elicera Therapeutics
Energy & power markets: Trading gets smarter while infrastructure races to catch up
14 maj 2025
Energy & power markets: Trading gets smarter while infrastructure races to catch up
Insights
Travel & Hospitality Technology: AI momentum builds while market growth stabilizes
06 maj 2025
Travel & Hospitality Technology: AI momentum builds while market growth stabilizes
Insights
Equity research Teneo AI: Volumes and margins growing faster than expected
06 maj 2025
Equity research Teneo AI: Volumes and margins growing faster than expected
Analysmaterial Teneo AI